Dynamic Technology Lab Private Ltd Invests $760,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Dynamic Technology Lab Private Ltd acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 10,983 shares of the company’s stock, valued at approximately $760,000.

Other institutional investors also recently bought and sold shares of the company. Olstein Capital Management L.P. increased its stake in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the period. Private Management Group Inc. increased its position in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. purchased a new position in shares of Henry Schein during the 4th quarter worth approximately $417,000. Savant Capital LLC lifted its holdings in shares of Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock valued at $322,000 after buying an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Henry Schein by 29.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock valued at $1,113,000 after buying an additional 3,650 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Barrington Research reissued an “outperform” rating and set a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Down 1.7 %

Shares of HSIC stock opened at $65.47 on Monday. The company has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a PEG ratio of 2.13 and a beta of 0.84. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $73.96 and a 200 day moving average price of $72.58. Henry Schein, Inc. has a twelve month low of $63.00 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the firm earned $0.66 EPS. The business’s quarterly revenue was up 5.8% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.